VRDN Latest Headlines

Viridian Grants 16,650 Inducement Options as Pipeline Progresses in Thyroid Eye Disease

Market Chameleon (Fri, 9-Jan 9:40 AM)

Viridian’s Veligrotug Advances with FDA Priority Review—Pivotal Data Shows Robust, Rapid Results for Thyroid Eye Disease

Market Chameleon (Mon, 22-Dec 11:17 AM)

Viridian Therapeutics Secures Nearly $900 Million, Eyes Profitability and Mid-2026 Product Launch

Market Chameleon (Thu, 6-Nov 10:37 AM)

Viridian Therapeutics Prices $251 Million Public Offering to Fuel Advancements in Rare Disease Therapies

Market Chameleon (Wed, 22-Oct 9:36 AM)